Another CDK4/6 Inhibitor Boosts PFS in Breast Cancer

(MedPage Today) -- Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news